Marta Chavero-Pieres

Marta Chavero-Pieres

Auto-generated profile, based on publicly available information

Marta Chavero-Pieres

Laboratory for Intestinal Neuro‐Immune Interaction, Translational Research Center for Gastrointestinal Disorders, Department of Chronic Diseases Metabolism and Ageing, KU Leuven Leuven Belgium

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2023 in Nature
Verified
Journal Article
Closed access
PDF file
MVMaria Francesca Viola
Maria Francesca Viola
MCMarta Chavero-Pieres
Marta Chavero-Pieres
EMElodie Modave
Elodie Modave
MDMarcello Delfini
Marcello Delfini
NSNathalie Stakenborg
Nathalie Stakenborg
GBGuy Boeckxstaens
Guy Boeckxstaens

12 April 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
TETony S. Eteläinen
Tony S. Eteläinen
MSM. Catarina Silva
M. Catarina Silva
JUJohanna K. Uhari-Väänänen
Johanna K. Uhari-Väänänen
FLFrancesca De Lorenzo
Francesca De Lorenzo
MJMaria H. Jäntti
Maria H. Jäntti
TMTimo T Myöhänen
Timo T Myöhänen
Tauopathies are neurodegenerative diseases that are characterized by accumulation of hyperphosphorylated tau protein, higher-order aggregates, and tau filaments. Protein phosphatase 2A (PP2A) is a major tau dephosphorylating phosphatase, and a decrease in its activity has been demonstrated in tauopathies, including Alzheimer’s disease. Prolyl oligopeptidase is a serine protease that is associated with neurodegeneration, and its inhibition normalizes PP2A activity without toxicity under pathological conditions. Here, we assessed whether prolyl oligopeptidase inhibition could protect against tau-mediated toxicity in cellular models in vitro and in the PS19 transgenic mouse model of tauopathy carrying the human tau-P301S mutation. We show that inhibition of prolyl oligopeptidase with the inhibitor KYP-2047 reduced tau aggregation in tau-transfected HEK-293 cells and N2A cells as well as in human iPSC–derived neurons carrying either the P301L or tau-A152T mutation. Treatment with KYP-2047 resulted in increased PP2A activity and activation of autophagic flux in HEK-293 cells and N2A cells and in patient-derived iNeurons, as indicated by changes in autophagosome and autophagy receptor markers; this contributed to clearance of insoluble tau. Furthermore, treatment of PS19 transgenic mice for 1 month with KYP-2047 reduced tau burden in the brain and cerebrospinal fluid and slowed cognitive decline according to several behavioral tests. In addition, a reduction in an oxidative stress marker was seen in mouse brains after KYP-2047 treatment. This study suggests that inhibition of prolyl oligopeptidase could help to ameliorate tau-dependent neurodegeneration.

13 November 2022 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
MCMarta Chavero‐Pieres
Marta Chavero‐Pieres
MVMaria Francesca Viola
Maria Francesca Viola
IAIris Appeltans
Iris Appeltans
SASaeed Abdurahiman
Saeed Abdurahiman
WGWilly Gsell
Willy Gsell
GBGuy Boeckxstaens
Guy Boeckxstaens
Background: Methods to study gastric emptying in rodents are time consuming or terminal, preventing repetitive assessment in the same animal. Magnetic resonance imaging (MRI) is a non‐invasive technique increasingly used to investigate gastrointestinal function devoid of these shortcomings. Here, we evaluated MRI to measure gastric emptying in control animals and in two different models of gastroparesis.Methods: Mice were scanned using a 9.4 Tesla MR scanner. Gastric volume was measured by delineating the stomach lumen area. Control mice were scanned every 30 min after ingestion of a 0.2 g meal and stomach volume was quantified. The ability of MRI to detect delayed gastric emptying was evaluated in models of morphine‐induced gastroparesis and streptozotocin‐induced diabetes.Key Results: Magnetic resonance imaging reproducibly detected increased gastric volume following ingestion of a standard meal and progressively decreased with a half emptying time of 59 ± 5 min. Morphine significantly increased gastric volume measured at t = 120 min (saline: 20 ± 2 vs morphine: 34 ± 5 mm3; n = 8–10; p < 0.001) and increased half emptying time using the breath test (saline: 85 ± 22 vs morphine: 161 ± 46 min; n = 10; p < 0.001). In diabetic mice, gastric volume assessed by MRI at t = 60 min (control: 23 ± 2 mm3; n = 14 vs diabetic: 26 ± 5 mm3; n = 18; p = 0.014) but not at t = 120 min (control: 21 ± 3 mm3; n = 13 vs diabetic: 18 ± 5 mm3; n = 18; p = 0.115) was significantly increased compared to nondiabetic mice.Conclusions and Inferences: Our data indicate that MRI is a reliable and reproducible tool to assess gastric emptying in mice and represents a useful technique to study gastroparesis in disease models or for evaluation of pharmacological compounds.

18 October 2026 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
MCMarta Chavero‐Pieres
Marta Chavero‐Pieres
MVMaria Francesca Viola
Maria Francesca Viola
ZWZheng Wang
Zheng Wang
MDMarcello Delfini
Marcello Delfini
IAIris Appeltans
Iris Appeltans
NSNathalie Stakenborg
Nathalie Stakenborg
Introduction: Obese patients suffer from cardiovascular, metabolic and gastrointestinal disorders, including constipation, proposed to result from high fat diet (HFD)‐induced enteric neuron loss. However, these studies used high‐fat purified diets, containing reduced amounts of fiber compared to non‐purified diets, known to alter gut physiology and microbiome composition. Therefore, we evaluated the effect of purified HFD‐induced obesity on enteric neuron density and gastrointestinal transit compared to its proper control diet, that is, a purified control diet. Methods: Wild type mice were fed a standard chow diet, purified low fat diet (LFD) or HFD. Colonic transit was measured via glass bead expulsion following 12, 18, and 24 weeks of diet. Colonic muscularis externa was collected for immunofluorescent stainings of enteric neurons. Results: Starting from 18 weeks of HFD, a decline in enteric neuron number was observed compared to LFD. In addition, delayed colonic transit was observed in HFD‐fed mice when compared to LFD‐fed animals after 18 weeks of exposure. Conclusions: Our study demonstrates that prolonged exposure to a HFD results in a reduced enteric neuron density and delayed colonic transit, and underscores the need to use a proper control diet when evaluating the impact of a HFD on gut physiology.